The US Food and Drug Administration (FDA) will have to consider again next year the possibility that snus could be a reduced-risk form of tobacco, following a series of applications from R.J. Reynolds Tobacco Company...
Written by Barnaby Page || 19th December 2017 || News analysis | Iqos | Snus | 
North America United States
Barnaby Page
Editorial director
Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications.
Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.
Our Key Benefits
The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
- Stay informed of any legal and market change in the sector that impacts your organisation
- Maximise resources by getting market and legal data analysis daily in one place
- Make smart decisions by understanding how the regulatory and market landscape evolves
- Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation
